Pegylated-Interferon and Ribavirin in Hepatitis C Patients With Persistently Normal Alanine Aminotransferase Levels
NCT00575627
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
150
Enrollment
OTHER
Sponsor class
Conditions
Chronic Hepatitis C
Interventions
DRUG:
Peg-Interferon alpha2a plus Ribavirin
Sponsor
University of Turin, Italy